Skip to main content

First Generic of Symbicort Launched

On July 31, 2023, Viatris and Kindeva launched Breyna™, an AB-rated generic version of AstraZeneca’s Symbicort® (budesonide/formoterol) metered-dose inhaler. This generic medication was approved by the FDA on March 15, 2022 and is used in the treatment of asthma and chronic obstructive pulmonary disease (COPD). Breyna’s™ wholesale acquisition cost (WAC) is approximately a 39% discount off Symbicort®. ProAct will work with our members taking Symbicort® to transition from the brand name medication to the lower cost generic alternative. 

First Generic of Symbicort Launched hero image

ProAct Logo ProAct Logo ProAct Logo
mobile image tablet image desktop image
Benny, the Chat Bot Greeter